BRIEF published on 02/04/2025 at 10:40, 1 year 7 months ago Valerio Therapeutics opte pour un recentrage stratégique Innovation Médicale Stratégie Financière Essais Cliniques Oncologie Valerio Therapeutics
PRESS RELEASE published on 02/04/2025 at 10:35, 1 year 7 months ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce un recentrage stratégique pour se concentrer sur le développement de médicaments early-stage et assurer une croissance durable. La société cherche un accord de financement à long terme Développement Financement Restructuration Médicaments Valerio Therapeutics
PRESS RELEASE published on 02/04/2025 at 10:35, 1 year 7 months ago Inside Information / Other news releases Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
BRIEF published on 10/01/2024 at 00:56, 1 year 11 months ago Valerio Therapeutics Reports First Half 2024 Financial Results Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies
BRIEF published on 10/01/2024 at 00:56, 1 year 11 months ago Valerio Therapeutics publie ses résultats financiers du premier semestre 2024 Résultats Financiers R&D Essai Clinique Valerio Therapeutics Anticorps À Domaine Unique
PRESS RELEASE published on 10/01/2024 at 00:51, 1 year 11 months ago Inside Information: News release on accounts, results Valerio Therapeutics annonce ses résultats financiers du Premier Semestre 2024 et fait le point sur ses activités, y compris l'acquisition d'Emglev Therapeutics et le développement de la plateforme PlatONTM Résultats Financiers Biotechnologie Valerio Therapeutics Emglev Therapeutics Plateforme PlatONTM
BRIEF published on 10/01/2024 at 00:45, 1 year 11 months ago Valerio Therapeutics publie ses résultats financiers du premier semestre 2024 et ses mises à jour stratégiques Résultats Financiers Plateforme PlatONTM Acquisition D'Emglev Essai Clinique VIO-01 Innovations Thérapeutiques
BRIEF published on 10/01/2024 at 00:45, 1 year 11 months ago Valerio Therapeutics Reports Half-Year 2024 Financial Results and Strategic Updates Financial Results Emglev Acquisition VIO-01 Clinical Trial PlatON™ Platform Therapeutic Innovations
PRESS RELEASE published on 10/01/2024 at 00:40, 1 year 11 months ago Inside Information: News release on accounts, results Valerio Therapeutics reports its half-year 2024 financial results and updates on its activities, including the acquisition of Emglev Therapeutics and progress on the VIO-01 trial Acquisition Financial Results Valerio Therapeutics VIO-01 Trial Emglev Therapeutics
PRESS RELEASE published on 09/30/2024 at 22:40, 1 year 11 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
Published on 09/29/2026 at 23:00, 52 minutes ago Abasca Resources Closes Non-Brokered Private Placement of $2.25 Million
Published on 09/29/2026 at 22:15, 1 hour 37 minutes ago CANEX Closes Oversubscribed $9.5 Million Equity Financing
Published on 09/29/2026 at 22:00, 1 hour 52 minutes ago Rocky Shore Closes Springdale Property Acquisition and Completes Initial Payments Under the Handcamp Property Option Agreement
Published on 09/29/2026 at 16:45, 7 hours 7 minutes ago Gold Terra Announces Visible Mineralization in Hole CMUP-005 in Early Sonic Drilling at the Con Mine Historical Tailings, Yellowknife, NWT
Published on 09/29/2026 at 21:30, 2 hours 22 minutes ago Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
Published on 09/29/2026 at 19:47, 4 hours 5 minutes ago EQS-Adhoc: Marley Spoon Group SE: MARLEY SPOON GROUP SE REPORTS H1 2026 RESULTS AND GUIDANCE FOR 2026
Published on 09/29/2026 at 19:15, 4 hours 37 minutes ago Pensão Amor: Discover Lisbon's Most Surprising Hotel
Published on 09/29/2026 at 19:14, 4 hours 38 minutes ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback
Published on 09/29/2026 at 19:14, 4 hours 38 minutes ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback
Published on 09/29/2026 at 17:40, 6 hours 12 minutes ago Infotel : Mise à disposition du rapport financier semestriel 2026.
Published on 09/29/2026 at 17:40, 6 hours 12 minutes ago LDC : Nombre total de droits de vote et d'actions composant le capital au 31.08.26.
Published on 09/29/2026 at 14:15, 9 hours 37 minutes ago 260929 BENETEAU Mise en oeuvre du programme de rachat d'actions
